International Research Grants in Congenital Muscular Dystrophy
Cure CMD's International Research Grants support innovative studies into the biology and treatment of L-CMD and αDG congenital muscular dystrophies.
Funder: Cure CMD
Due Dates: July 27, 2026: Letter of Intent (LOI) deadline (11:59 pm applicant's local time) | September 14, 2026: Full Proposal deadline (By Invitation Only, 11:59 pm applicant's local time)
Funding Amounts: Up to $100,000 over 2 years (L-CMD) or $50,000 over 1–2 years (αDG); separate application per subtype.
Summary: Supports international research advancing understanding or treatment of congenital onset laminopathies (L-CMD) and dystroglycanopathies (αDG).
Key Information: Full proposals are by invitation only following LOI review.
Description
Cure CMD's International Research Grants in Congenital Muscular Dystrophy fund innovative research projects that advance scientific understanding and potential therapeutic strategies for two specific CMD subtypes: Congenital Onset Laminopathies (L-CMD) and Congenital Onset Dystroglycanopathies (αDG). The program aims to propel research with the potential to translate into new treatments or improved care for individuals affected by these rare neuromuscular disorders. Each subtype is considered separately, and applicants may submit independent applications for one or both categories.
